MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt the progress of degenerative diseases.

WASE, a modular bioenergy production and wastewater treatment company based in London, UK, have secured a £1m Seed funding round to accelerate the commercialisation of their technology to help the food and drinks industry become net carbon neutral.